Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1996-04-19
2004-02-24
Duffy, Patricia A. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069700
Reexamination Certificate
active
06696557
ABSTRACT:
TECHNICAL FIELD
This application relates to a receptor protein tyrosine kinase ligand and its uses. In particular this application relates to the production and use of purified forms of AL-2 and related proteins.
BACKGROUND
Protein neurotrophic factors, or neurotrophins, which influence growth and development of the vertebrate nervous system, are believed to play an important role in promoting the differentiation, survival, and function of diverse groups of neurons in the brain and periphery. Neurotrophic factors are believed to have important signaling functions in neural tissues, based in part upon the precedent established with nerve growth factor (NGF). NGF supports the survival of sympathetic, sensory, and basal forebrain neurons both in vitro and in vivo. Administration of exogenous NGF rescues neurons from cell death during development. Conversely, removal or sequestration of endogenous NGF by administration of anti-NGF antibodies promotes such cell death (Heumann,
J. Exp. Biol
., 132:133-150 (1987); Hefti,
J. Neurosci
., 6:2155-2162(1986); Thoenen et al.,
Annu. Rev. Physiol
., 60:284-335 (1980)).
Additional neurotrophic factors related to NGF have since been identified. These include brain-derived neurotrophic factor (BDNF) (Leibrock, et al.,
Nature
, 341:149-152 (1989)), neurotrophin-3 (NT-3) (Kaisho, et al.,
FEBS Lett
., 266:187 (1990); Maisonpierre, et al.,
Science
, 247:1446 (1990); Rosenthal, et al.,
Neuron
, 4:767 (1990)), and neurotrophin 4/5 (NT-4/5) (Berkmeier, et al.,
Neuron
, 7:857-866 (1991)).
Neurotrophins, similar to other polypeptide growth factors, affect their target cells through interactions with cell surface receptors. According to our current understanding, two kinds of transmembrane glycoproteins act as receptors for the known neurotrophins. Equilibrium binding studies have shown that neurotrophin-responsive neuronal cells possess a common low molecular weight (65,000-80,000 Daltons), a low affinity receptor typically referred to as p75
LNGFR
or p75, and a high molecular weight (130,000-150,000 Dalton) receptor. The high and low affinity receptors are members of the trk family of receptor tyrosine kinases.
Receptor tyrosine kinases are known to serve as receptors for a variety of protein factors that promote cellular proliferation, differentiation, and survival. In addition to the trk receptors, examples of other receptor tyrosine kinases include the receptors for epidermal growth factor (EGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF). Typically, these receptors span the cell membrane, with one portion of the receptor being intracellular and in contact with the cytoplasm, and another portion of the receptor being extracellular. Binding of a ligand to the extracellular portion of the receptor induces tyrosine kinase activity in the intracellular portion of the receptor, with ensuing phosphorylation of various intracellular proteins involved in cellular signaling pathways.
Recently, a receptor tyrosine kinase subclass referred to as the Eph receptor subclass or family has been identified. Eph was the first member of this Eph subclass of receptor tyrosine kinases to be identified and characterized by molecular cloning (Hirai et al.,
Science
, 238:1717-1720 (1987)). The name Eph is derived from the name of the cell line from which the Eph cDNA was first isolated, the erythropoietin-producing human hepatocellular carcinoma cell line, ETL-1. The general structure of Eph is similar to that of other receptor tyrosine kinases and consists of an extracellular domain, a single membrane spanning region, and a conserved tyrosine kinase catalytic domain. However, the structure of the extracellular domain of Eph, which comprises an immunoglobulin (Ig)-like domain at its amino terminus, followed by a cysteine-rich region and two fibronectin type III repeats in close proximity to the transmembrane domain, is completely distinct from that of previously described receptor tyrosine kinases. The juxtamembrane domain and carboxy-terminus regions of Eph also are unrelated to the corresponding regions of other tyrosine kinase receptors.
Newly discovered members of the Eph receptor family include Elk, Cek5, Mek4, Cek4, Hek/Hek4 (Sajjadi et al.,
The New Biologist
, 3:769-778 (1991)), Cek6 through Cek10 (Sajjadi et al.,
Oncogene
, 8:1807-13 (1993), Sek, Hek2, and Ehk3 (Tuzi, et al.,
Br. J. Cancer
, 69:417-421 (1994); Zhou, et
J. Neurosci. Res
., 37:129-143 (1994)). Other Eph-related receptor kinases that have been identified include Sek (Gilardi-Hebenstreit et al,
Oncogene
, 7:2499-2506 (1992)), Eck (Lindberg et al.,
Mol. Cell. Biol
., 10:6316-6324 (1990)), Elk (Lhotak et al.,
Mol. Cell. Biol
., 11:2496-2502 (1991)), Eek (Chan et al.,
Oncogene
, 6:1057-1061 (1991)), Rek7 (Winslow et al.,
Neuron
, 14:973-981 (1995). Rek7 is a rat homolog of chicken Cek7 and closely related to Ehk-1 (Davis et al.,
Science
, 266:816-819 (1994)) and bsk (Maisonpierre et al.,
Oncogene
, 8:3277-3288 (1993); Zhou et al.,
J. Neurosci. Res
,. 37:129-143 (1994)); the Rek7 cDNA corresponds to a splice variant of Ehk-1, lacking the first of two tandem fibronectin type-III domains. Human homologs of the chicken Cek receptors are referred to as Hek receptors (See WO 95/28484, which is incorporated herein by reference). For example, Hek5 (Fox et al.,
Oncogene
, 10(5):897-905 (1995); WO 95/28484) is the human homolog of chicken Cek5. The amino acid sequence of Hek5 is very closely related (96% amino acid identity in the catalytic domain) to the chicken receptor Cek5 (Pasquale et al.,
J. Neuroscience
, 12:3956-3967 (1992); Pasquale,
Cell Regulation
, 2:523-534 (1991)). A portion of the Hek5 sequence was previously disclosed as Erk, a human clone encoding about sixty amino acids (Chan et al.,
Oncogene
, 6:1057-1061 (1991)). Mature Erk showed high homology with Cek5 (92.5%) and mouse Nuk (99.1%) (Kiyokawa et al.,
Cancer Res
., 54 (14):3645-50 (1994)). Other human Eph-family receptors include Hek (Wicks et al.,
Proc. Natl. Acad. Sci. USA
, 89(5):161 1-1615 (1992); also known as Hek4), Hek2 (Bohme et al.,
Oncogene
, 8:2857-2862 (1993)), Heks 7, 8 and 11 (WO 95/28484), Hek3, which is a homolog of rat Eek and murine Mdk-1, and Hek 12, which is a homolog of rat Ehk2.
Many of the Eph-receptor family members are “orphan receptors.” However, recently, ligands have been reported including B61, an Eck receptor ligand (Bartley et al.,
Nature
, 368:558-560 (1994) and Pandey et al.,
Science
, (1995) 268:567-569), Elf-1, a Mek4 and Sek receptor ligand (Cheng et al., Cell, (1995) 82:371-381; Cheng et al.,
Cell
, 79:157-168 (1994)), Htk-L (Bennett et al.,
Proc. Natl. Acad. Sci. USA
, 92(6):1866-70 (1995)), AL-1 (Winslow et al,
Neuron
, 14:973-981 (1995)) and RAGS (Drescher et al.,
Cell
, (1995) 82:359-370), which are Rek7 ligands, Ehk-1-L (Davis et al.,
Science
, 266:816-819 (1994); see also efl-2 in WO 95/27060), Cek5-L, and Lerk2 (Beckmann et al.,
EMBO J
., 13:3757-3762 (1994)).
Aberrant expression of receptor tyrosine kinases correlates with transforming ability. This relationship includes members of the Eph subclass of receptor tyrosine kinases. For example, carcinomas of the liver, lung, breast and colon show elevated expression of Eph. Unlike many other tyrosine kinases, this elevated expression can occur in the absence of gene amplification or rearrangement. Such involvement of Eph in carcinogenesis also has been shown by the formation of foci of NIH 3T3 cells in soft agar and of tumors in nude mice following overexpression of Eph. Moreover, Hek has been identified as a leukemia-specific marker present on the surface of a pre-B cell leukemia cell line. As with Eph, Hek also was overexpressed in the absence of gene amplification or rearrangements in, for example, hemopoietic tumors and lymphoid tumor cell lines. Over-expression of Myk-1 (a murine homolog of human Htk (Bennett et al.,
J. Biol. Chem
., 269(19): 14211-8 (1994)) was found in the undifferentiated and invasive mammary tumors of transgenic mice expressing the Ha-ras oncogene. (Andres et a
Agarwal Atulya
Dreger, Esq. Ginger R.
Duffy Patricia A.
Genentech Inc.
Heller Ehrman White & McAuliffe LLP
LandOfFree
AL-2 neurotrophic factor nucleic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with AL-2 neurotrophic factor nucleic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AL-2 neurotrophic factor nucleic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3353881